Adaptive Biotechnologies vs Sarepta
Adaptive Biotechnologies vs Sarepta, compared side by side on 11 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Sarepta on 21/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 21/100
- agent readiness: 39/100 against 34/100
Sarepta
- domain rating: 68/100 against 61/100
At a glance
| Measure | Adaptive Biotechnologies | Sarepta |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Services |
| Founded | 2009 | Not published |
| Headquarters | Seattle, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Sarepta |
|---|---|---|
| Employees | Not published | 1,162 |
| Open roles | Not published | 19 |
| Total funding | $300M | Not published |
| Latest round | Series D | Not published |
| LinkedIn followers | Not published | 138,724 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Sarepta |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 21/100 |
| Traction | Not published | 20/100 |
| Search visibility | Not published | 25/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 68/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Sarepta |
|---|---|---|
| Hosting | Self Managed | AWS |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Not detected |
What users say
| Measure | Adaptive Biotechnologies | Sarepta |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 1 thread |
“Sarepta Therapeutics is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. $SRP”r/
Adaptive Biotechnologies vs Sarepta: common questions
Which is better, Adaptive Biotechnologies or Sarepta?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 21/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 11 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Sarepta compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 21/100), agent readiness (39/100 against 34/100). Sarepta leads on domain rating (68/100 against 61/100).
What do real users say about Adaptive Biotechnologies and Sarepta?
Sarepta: 1 positive and 0 negative mentions across 1 Reddit threads we track.
Read the full Adaptive Biotechnologies review and pricing or the Sarepta review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.